This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goadsby PJ (2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13: 39–44
Goadsby PJ (2007) Serotonin receptor ligands: treatments of acute migraine and cluster headache. Handb Exp Pharmacol 177: 129–143
Bigal M et al. (2007) Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden. Headache 47: 475–479
Smith TR et al. (2005) Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45: 983–991
Edmeads J (2005) Defining response in migraine: which endpoints are important? Eur Neurol 53 (Suppl 1): 22–28
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Andrew Charles is a consultant for AGA Medical and Astra Zeneca, and has received speaker honoraria from Merck and Ortho McNeill. Kevin C Brennan declared no competing interests.
Rights and permissions
About this article
Cite this article
Charles, A., Brennan, K. Sumatriptan–naproxen combination for acute migraine. Nat Rev Neurol 3, 604–605 (2007). https://doi.org/10.1038/ncpneuro0615
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0615